Skip to main content

Table 1 Basic characteristics of patients with IMA and NMA at diagnosis

From: Postoperative survival of pulmonary invasive mucinous adenocarcinoma versus non-mucinous invasive adenocarcinoma

Variables

IMA

NMA

p

 

303

20,611

 

Age (years)

≤ 65

142 (46.86%)

9044 (43.88%)

0.299

> 65

161 (53.14%)

11,567 (56.12%)

Sex

Male

116 (38.28%)

8727 (42.34%)

0.156

Female

187 (61.72%)

11,884 (57.66%)

Marital status

Single

75 (24.75%)

5504 (26.70%)

0.029

Divorced

27 (8.91%)

2770 (13.44%)

Married

201 (66.34%)

12,337 (59.86%)

Race

Black

32 (10.56%)

1686 (8.18%)

0.32

Other

30 (9.90%)

2030 (9.85%)

White

241 (79.54%)

16,895 (81.97%)

Location

Upper

102 (33.66%)

12,781 (62.01%)

< 0.0001

Lower

180 (59.41%)

6312 (30.62%)

Middle

15 (4.95%)

1033 (5.01%)

Other

6 (1.98%)

485 (2.35%)

Grade

Grade I

179 (59.08%)

3692 (17.91%)

< 0.0001

Grade II

51 (16.83%)

9436 (45.78%)

Grade III

9 (2.97%)

6353 (30.82%)

Grade IV

0 (0.00%)

130 (0.63%)

Unknown

64 (21.12%)

1000 (4.85%)

Laterality

Left

135 (44.55%)

8307 (40.30%)

0.134

Right

168 (55.45%)

12,304 (59.70%)

T

T1

135 (44.55%)

13,448 (65.25%)

< 0.0001

T2

74 (24.42%)

4900 (23.77%)

T3

44 (14.52%)

1443 (7.00%)

T4

50 (16.50%)

820 (3.98%)

N

N0

286 (94.39%)

14,863 (72.11%)

< 0.0001

N1

9 (2.97%)

2888 (14.01%)

N2

8 (2.64%)

2795 (13.56%)

N3

0 (0.00%)

65 (0.32%)

Stage

IA1

19 (6.27%)

939 (4.56%)

0.0001

IA2

55 (18.15%)

5399 (26.19%)

IA3

55 (18.15%)

4261 (20.67%)

IB

44 (14.52%)

2105 (10.21%)

IIA

27 (8.91%)

964 (4.68%)

IIB

45 (14.85%)

3127 (15.17%)

IIIA

55 (18.15%)

3229 (15.67%)

IIIB

3 (0.99%)

569 (2.76%)

IIIC

0 (0.00%)

18 (0.09%)

Size (median [IQR])

35.000 [20.000, 60.000]

25.000 [18.000, 36.000]

< 0.0001

Operation

Lobectomy

263 (86.80%)

16,849 (81.75%)

0.138

Lobectomy extended

7 (2.31%)

855 (4.15%)

Other sublobar

3 (0.99%)

107 (0.52%)

Pneumonectomy

6 (1.98%)

691 (3.35%)

Segmentectomy

5 (1.65%)

565 (2.74%)

Wedge

19 (6.27%)

1544 (7.49%)

Chemotherapy

No

254 (83.83%)

14,909 (72.34%)

< 0.0001

Yes

49 (16.17%)

5702 (27.66%)

Radiation

No

294 (97.03%)

18,256 (88.57%)

< 0.0001

Yes

9 (2.97%)

2355 (11.43%)